Virtual Reality (VR) Paediatric Tracheostomy Training

April 1, 2024 updated by: Jonathan Abass, University of Manchester

Can Remote Training of Paediatric Emergency Tracheostomy Simulation be Performed Using VR Technology?

This study aims to evaluate the use of an unsupervised virtual reality training tool. This tool is used to teach nurses, doctors and other healthcare workers and their students how to manage tracheostomy emergencies in children.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

69

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthcare student
  • Clinical experience needed
  • Healthcare staff
  • Based at Manchester University Foundation Trust, or The University of Manchester

Exclusion Criteria:

  • Not a healthcare student
  • Not a healthcare student - have no clinical experience
  • Not healthcare staff but working in the National Health Service
  • Not based at Manchester University Foundation Trust, or The University of Manchester

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Performance in simulation (time to key specific intervention, time to completion of scenario, and number of correct interventions completed)
Time Frame: Measured at the beginning of study and 1 week.

Test the improvement in simulated performance in a pre- and post-test method.

Time to key specific intervention and total scenario times will be measured in seconds, with a smaller number indicating better performance.

Number of correct interventions will be simple numerical with higher number indicating better performance.
Measured at the beginning of study and 1 week.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge using a bespoke knowledge multiple choice questionnaire adapted from a validated question bank.
Time Frame: Measured at the beginning of study,1 week and 4 weeks post intervention.
Measurement of knowledge in a pre- and post-test method. The a higher score will indicate more knowledge. Minimum values are 0, maximum value of 23.
Measured at the beginning of study,1 week and 4 weeks post intervention.
Participant satisfaction measured using a bespoke data collection tool.
Time Frame: 1 week post initiation of intervention
Likert questionnaire
1 week post initiation of intervention
Virtual Reality Sickness
Time Frame: 1 week post initiation of intervention

Measure of participant comfort using the validated Virtual Reality Sickness Questionnaire.

Lower score is better. The score can range from 0-27.
1 week post initiation of intervention
Usability using the validated system usability scale
Time Frame: 1 week post initiation of intervention

Measure of usability using the validated System Usability Scale

Calculation of the score is complex, and will follow the guidance in the below academic work:

https://www.researchgate.net/publication/228593520_SUS_A_quick_and_dirty_usability_scale
1 week post initiation of intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Manchester

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2024

Primary Completion (Estimated)

July 10, 2024

Study Completion (Estimated)

July 10, 2024

Study Registration Dates

First Submitted

March 25, 2024

First Submitted That Met QC Criteria

April 1, 2024

First Posted (Actual)

April 5, 2024

Study Record Updates

Last Update Posted (Actual)

April 5, 2024

Last Update Submitted That Met QC Criteria

April 1, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2024-18304-33663
  • 336664 (Other Identifier: Integrated Research Application System (IRAS))

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Educational Study

Clinical Trials on Virtual reality (VR) tracheostomy educational tool

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe